Literature DB >> 16889951

Optimum expression of adult lung function based on all-cause mortality: results from the Reykjavik study.

S Chinn1, T Gislason, T Aspelund, V Gudnason.   

Abstract

A variety of reference curves are used to derive predicted values for adult lung function, even within ethnically similar populations. Alternatives to percentage predicted value are sometimes used to allow for height in research. Strength of association with total mortality can be used to choose the optimal expression, between forced expiratory volume in 1s (FEV(1)) divided by height(2), FEV(1)/height(3), FEV(1)% predicted and difference from predicted. Data from the Reykjavik Study cohort, 1976-2002, included 5544 men and 8062 women randomly selected from the population. Total mortality was analysed by Cox proportional hazards regression in relation to each height-adjusted measure, allowing for age group, period of recruitment and body mass index, and smoking before or at baseline. FEV(1)/height(2) and FEV(1)/height(3) had stronger associations with mortality than FEV(1)% predicted and difference from predicted in men and in women. There were similar findings for forced vital capacity (FVC) in non-smokers and in women. FEV(1)/height(2) was slightly better predictive than FEV(1)/height(3) in men, but distributions of FEV(1)/height(3) in men and women were closer than those of FEV(1)/height(2). Clinical practise and epidemiological research would benefit from agreement on how to adjust lung function for height. Replication of these analyses in other cohort studies would inform the choice between FEV(1)/height(2) and FEV(1)/height(3).

Entities:  

Mesh:

Year:  2006        PMID: 16889951     DOI: 10.1016/j.rmed.2006.06.009

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  15 in total

1.  Spirometry Reference Equations from the HCHS/SOL (Hispanic Community Health Study/Study of Latinos).

Authors:  Lisa LaVange; Sonia M Davis; John Hankinson; Paul Enright; Rebbecca Wilson; R Graham Barr; Thomas K Aldrich; Ravi Kalhan; Hector Lemus; Ai Ni; Lewis J Smith; Gregory A Talavera
Journal:  Am J Respir Crit Care Med       Date:  2017-10-15       Impact factor: 21.405

2.  ARTP statement on pulmonary function testing 2020.

Authors:  Karl Peter Sylvester; Nigel Clayton; Ian Cliff; Michael Hepple; Adrian Kendrick; Jane Kirkby; Martin Miller; Alan Moore; Gerrard Francis Rafferty; Liam O'Reilly; Joanna Shakespeare; Laurie Smith; Trefor Watts; Martyn Bucknall; Keith Butterfield
Journal:  BMJ Open Respir Res       Date:  2020-07

3.  The use of ethnically specific norms for ventilatory function in African-American and white populations.

Authors:  P G J Burney; R L Hooper
Journal:  Int J Epidemiol       Date:  2012-03-19       Impact factor: 7.196

4.  Best lung function equations for the very elderly selected by survival analysis.

Authors:  Martin R Miller; Mikael Thinggaard; Kaare Christensen; Ole F Pedersen; Torben Sigsgaard
Journal:  Eur Respir J       Date:  2014-01-31       Impact factor: 16.671

5.  Why does lung function predict mortality? Results from the Whitehall II Cohort Study.

Authors:  Séverine Sabia; Martin Shipley; Alexis Elbaz; Michael Marmot; Mika Kivimaki; Francine Kauffmann; Archana Singh-Manoux
Journal:  Am J Epidemiol       Date:  2010-10-20       Impact factor: 4.897

6.  Staging the severity of chronic obstructive pulmonary disease in older persons based on spirometric Z-scores.

Authors:  Carlos A Vaz Fragoso; John Concato; Gail McAvay; H Klar Yaggi; Peter H Van Ness; Thomas M Gill
Journal:  J Am Geriatr Soc       Date:  2011-09-13       Impact factor: 5.562

7.  Persistent Chlamydia Pneumoniae serology is related to decline in lung function in women but not in men. Effect of persistent Chlamydia pneumoniae infection on lung function.

Authors:  Thorarinn Gislason; Vilmundur Guðdnason; Bryndis Benediktsdottir; Isleifur Olafsson; Thor Aspelund; Bjarni Thjodleifsson; Christer Janson
Journal:  BMC Pulm Med       Date:  2010-08-25       Impact factor: 3.317

8.  Pulmonary function impairment may be an early risk factor for late-life cognitive impairment.

Authors:  Jean-Sébastien Vidal; Thor Aspelund; Maria K Jonsdottir; Palmi V Jonsson; Tamara B Harris; Oscar L Lopez; Vilmundur Gudnason; Lenore J Launer
Journal:  J Am Geriatr Soc       Date:  2013-01       Impact factor: 5.562

9.  Whole-genome analyses of lung function, height and smoking.

Authors:  Luc Janss; Torben Sigsgaard; Daniel Sorensen
Journal:  Ann Hum Genet       Date:  2014-08-01       Impact factor: 1.670

10.  Prevalence of airflow obstruction in nonsmoking older individuals using different spirometric criteria: the AGES Reykjavik Study.

Authors:  Solrun Bjork Runarsdottir; Gunnar Gudmundsson; Thor Aspelund; Tamara B Harris; Lenore J Launer; Vilmundur Gudnason; Thorarinn Gislason
Journal:  COPD       Date:  2013-04-05       Impact factor: 2.409

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.